The World Health Organisation (WHO) has approved the use of dexamethasone for critically-ill COVID-19 patients. Tedros Ghebreyesus, director-general of WHO, disclosed this during a press briefing on Monday. On June
The World Health Organisation (WHO) has approved the use of dexamethasone for critically-ill COVID-19 patients. Tedros Ghebreyesus, director-general of WHO, disclosed this during a press briefing on Monday. On June